A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs
MuSt-PC
1 other identifier
observational
659
1 country
1
Brief Summary
A nationwide, cross-sectional study, to determine the prevalence of symptoms of patients in the palliative phase in various care settings will be performed within a set period of two weeks in September 2018 and two weeks in November 2018. The participating settings will be selected by a total of seven coordinators, one for each consortium of palliative care in the Netherlands. To identify common combinations of symptoms and for multidimensional screening the Utrecht Symptom Diary-4 Dimensional (USD-4D) and Utrecht Symptom Diary (USD), a Dutch instrument based on the Edmonton Symptom Assessment Scale, will be used. The current protocol focuses on the cross-sectional study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2018
CompletedFirst Submitted
Initial submission to the registry
September 7, 2018
CompletedFirst Posted
Study publicly available on registry
September 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedApril 19, 2024
April 1, 2024
2 years
September 7, 2018
April 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of multiple, simultaneously occurring symptoms
Prevalence of multiple, simultaneously occurring symptoms (symptom clusters) in patients in the palliative phase in Dutch care settings (GP practices, home care facilities, general and academic hospitals, hospices).
4 weeks
Secondary Outcomes (6)
Prevalence of each separate symptom
4 weeks
Clinically relevant symptoms
4 weeks
Quality of life (single question with numeric rating scale)
4 weeks
Symptom burden (multidimensional questions of Utrecht Symptom Diary-4Dimensional)
4 weeks
Symptoms per care setting
4 weeks
- +1 more secondary outcomes
Study Arms (1)
Patients in the palliative stage
Adult patients in various settings will be included (General Practioners practices, home care facilities, general and academic hospitals, hospices) and with any underlying life-limiting disease.
Eligibility Criteria
Adult patients in various settings will be included (GP practices, home care facilities, general and academic hospitals, hospices) and with any underlying life-limiting disease
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Groningen
Groningen, 9713 GZ, Netherlands
Study Officials
- PRINCIPAL INVESTIGATOR
An KL Reyners, MD, PhD
University Medical Center Groningen
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 7, 2018
First Posted
September 11, 2018
Study Start
September 1, 2018
Primary Completion
September 1, 2020
Study Completion
December 1, 2020
Last Updated
April 19, 2024
Record last verified: 2024-04